Over- and Undertreatment With Levothyroxine.

Area of Science:

• Endocrinology
• Pharmacology
• Public Health

Background:

• Levothyroxine is a widely prescribed medication for thyroid conditions.
• Inadequate treatment, including overtreatment and undertreatment, is a common issue.
• Limited research exists on the factors influencing suboptimal levothyroxine therapy.

Purpose of the Study:

• To investigate the prevalence and determinants of inadequate levothyroxine treatment.
• To analyze factors associated with levothyroxine dosage in a population-based study.

Main Methods:

• Analysis of data from 2938 participants in the population-based Rhineland Study.
• Logistic regression used to identify determinants of overtreatment (thyrotropin <0.56 mU/L) and undertreatment (thyrotropin >4.27 mU/L).
• Linear regression employed to assess determinants of levothyroxine dose.

Main Results:

• 23% of participants were taking levothyroxine, with 18% overtreated and 4% undertreated.
• Individuals over 70 were four times more likely to be overtreated (OR = 4.05).
• Higher levothyroxine doses correlated with increased risk of both overtreatment and undertreatment. Iodine supplementation was linked to lower doses, while longer levothyroxine use correlated with higher doses.

Conclusions:

• Levothyroxine intake is high but often suboptimal, even with monitoring.
• Findings emphasize the necessity of precise levothyroxine dosing.
• Consideration for deintensifying treatment in certain cases is warranted.